SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cel-Sci Corp (AMEX:CVM) (was HIV)
CVM 5.020-4.9%11:38 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom Shutters who wrote (2708)9/28/1999 8:15:00 AM
From: Alan Brezin  Read Replies (1) of 2836
 
Tom, I agree the news is sketchy. It is a "LEAPS" of faith for shareholders, imo. However, if HIV retains a major interest in LEAPS and any new investors in Max Pharama earn their interest in fair proportion to their investment, it would seem like a fair idea.

Frankly, why wouldn't an investor interested in LEAPS be interested in owning a pro rata share of Multikine if it was worth a damn? Why not have the diversity in your biotech investment, especially since the two technologies are supposed to be complimentary as I understand them to be? Or is LEAPS not worth that much that Geert doesn't want to give up a share in Multikine for what it gets for LEAPS and funnels back to Multikine perhaps?

Only the shadow knows?

Alan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext